Stay updated on Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page
- Check3 days agoChange DetectedDifference0.7%
- Check10 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1.0%
- Check17 days agoChange DetectedThe page has been updated to reflect the latest version as v2.16.3, replacing the previous version v2.16.2. The phrasing regarding the last update has also changed from 'Estimated' to a definitive statement.SummaryDifference0.0%
- Check24 days agoChange DetectedThe page has been updated with new dates for clinical trial milestones and revisions to the informed consent form, indicating a shift in the timeline and documentation related to the study.SummaryDifference0.5%
- Check32 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.4%
- Check39 days agoChange DetectedThe page has updated the name of the medical center to 'MaineHealth Maine Medical Center- Scarborough' and has revised the version number to v2.16.0.SummaryDifference0.2%
Stay in the know with updates to Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.